Smiths Group PLC Appoint new CEO for Smiths Medical

Smiths Group Plc

Smiths Group plc (LON: SMIN) has today announced the appointment of JehanZeb Noor as Chief Executive Officer of Smiths Medical. JehanZeb will be part of Smiths Group’s Executive Committee and report to Andy Reynolds Smith, CEO of Smiths Group plc.

JehanZeb will take up the role on 1 July 2019 and will oversee the separation of Smiths Medical, which is expected to be completed during the first half of CY2020.

JehanZeb joins from Amcor Flexibles Inc., where he led the Healthcare North America business and Global Sales for Medical. Amcor is a specialist producer of sterile packaging for the global medical device and pharmaceuticals industries. During his three-year tenure at Amcor he drove a significant improvement in margin and revenue growth and led the integration of a major acquisition. Prior to joining Amcor, JehanZeb was a Partner at McKinsey & Company where he served for 9 years. He has a deep understanding of the MedTech supply chain, operations, distribution, product development and regulatory approval processes. JehanZeb holds a BSc in Finance and a BSc and MSc in Mechanical Engineering from the Massachusetts Institute of Technology.

Andy Reynolds Smith, Chief Executive of Smiths Group plc, commented:

“I look forward to working with JehanZeb as we continue building a strong, sustainable future for Smiths Medical and progress the separation of the business from Smiths Group. I am confident that JehanZeb’s intimate understanding of the MedTech industry combined with his strong track record of effective leadership, delivering growth and enhanced performance will make him a great success.”

JehanZeb Noor, Smiths Medical Chief Executive Officer Designate, commented:

“Smiths Medical is an industry leader, offering high quality specialised medical devices across the globe with significant investment in new products. The company will begin an exciting new chapter when it separates from the wider Group and I’m looking forward to the opportunity to join the team and lead the journey ahead to achieve our full potential, while serving a life saving mission.”

Share on:

Latest Company News

Smiths Group to sell Smiths Interconnect to Molex for £1.3 billion

Smiths Group plc has agreed to sell Smiths Interconnect to Molex Electronic Technologies Holdings, LLC, a Koch company, for an enterprise value of £1.3 billion, equivalent to 15.1 times FY2025 EBITDA.

Smiths Group reports strong FY2025 results, exceeding growth guidance

Smiths Group delivered full-year results to 31 July 2025 ahead of guidance, with organic revenue up 8.9% to £3.34bn and operating profit rising 13.1% to £580m. Headline EPS increased 14.8% to 121.2p, ROCE reached 18.1%, and cash conversion was 99%.

Smiths Group Plc announces Board and Committee changes ahead of AGM

Smiths Group has confirmed a series of Board and Committee changes as part of its succession planning. Mark Seligman, Noel Tata and Karin Hoeing will retire following the AGM on 19 November 2025. Dame Ann Dowling will become Senior Independent Director, while Alister Cowan will chair the Remuneration & People Committee. Pam Cheng will join the Audit & Risk Committee.

Smiths Group Plc delivers strong financial results, reaffirms full year guidance

Smiths Group plc reports robust half-year results, showcasing strong revenue growth, margin expansion, and strategic actions to enhance shareholder value.

Smiths Group Plc strategy shift to enhance shareholder value

Smiths Group Plc is set to enhance shareholder returns by focusing on its core businesses, John Crane and Flex-Tek, while divesting Smiths Interconnect.

Smiths Group Plc appoints Julian Fagge as CFO, to succeed Clare Scherrer

Smiths Group plc appoints Julian Fagge as new CFO, succeeding Clare Scherrer, as they announce an upgrade in their FY2025 growth forecast.

    Search

    Search